| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/27/2000 | WO2000023077A1 Method for treating schizophrenia and means used in said method |
| 04/27/2000 | WO2000023076A1 Aminophenoxyacetic acid derivatives as neuroprotectants |
| 04/27/2000 | WO2000023075A1 Analgesics |
| 04/27/2000 | WO2000023074A1 Pharmaceutical composition containing decursin |
| 04/27/2000 | WO2000023073A1 Bioflavonoids as plasma high density lipoprotein level increasing agent |
| 04/27/2000 | WO2000023072A1 Irrigation solution containing mapk inhibitors and their use for treating pain and inflammation |
| 04/27/2000 | WO2000023071A1 Pharmaceutical formulations useful to treat inflammatory and immune disorders |
| 04/27/2000 | WO2000023070A1 Process for purification of solvents useful in the preparation of pharmaceutical compositions |
| 04/27/2000 | WO2000023069A1 Ubiguinone-containing composition suitable for promoting enhanced intramitochondrial transportation of ubiquinones and methods of using same |
| 04/27/2000 | WO2000023068A2 Fumaric acid microtablets |
| 04/27/2000 | WO2000023067A1 Method for the treatment of mania and bipolar disorder |
| 04/27/2000 | WO2000023066A2 Irrigation solution and method for inhibition of pain and inflammation |
| 04/27/2000 | WO2000023065A2 Storable active substance concentrate with formoterol |
| 04/27/2000 | WO2000023064A1 Treatment of dyspepsia |
| 04/27/2000 | WO2000023063A2 Methods for inhibiting diabetic complications |
| 04/27/2000 | WO2000023062A2 Irrigation solution and method for inhibition of pain and inflammation |
| 04/27/2000 | WO2000023061A2 Irrigation solution and method for inhibition of pain and inflammation |
| 04/27/2000 | WO2000023060A2 Method of treating immunological disorders mediated by t-lymphocytes |
| 04/27/2000 | WO2000023059A2 Use of anticonvulsant derivatives for treating alcohol dependency |
| 04/27/2000 | WO2000023058A2 Use of an antianaerobic-bacterial or/and antiprotozoal agent (preferably metronidazole) in the manufacture of a medicament for the treatment of haemorrhoids |
| 04/27/2000 | WO2000023057A2 Atypical antiphsychotic in combination with acetylcholinesterase inhibitor for improving cognition |
| 04/27/2000 | WO2000023056A2 The use of dopaminergic agents in the management of sexual dysfunction |
| 04/27/2000 | WO2000023055A1 Oral pulsed dose drug delivery system |
| 04/27/2000 | WO2000023052A1 Liposome-entrapped topoisomerase inhibitors |
| 04/27/2000 | WO2000023051A1 Aerosol ointment compositions and method of manufacture |
| 04/27/2000 | WO2000023050A1 Propofol composition comprising pentetate |
| 04/27/2000 | WO2000023048A1 Perfusate preparation for ophthalmic operation |
| 04/27/2000 | WO2000023045A1 Pharmaceutical composition with gastric residence and controlled release |
| 04/27/2000 | WO2000023043A1 Uv protection compositions |
| 04/27/2000 | WO2000023042A1 Uv protection compositions |
| 04/27/2000 | WO2000023037A1 Two chamber cartridge for atomizers |
| 04/27/2000 | WO2000023023A1 Methods of hydrating mucosal surfaces |
| 04/27/2000 | WO2000023022A1 Method and compositions for in situ formation of protective and/or medicated films on body tissue |
| 04/27/2000 | WO2000007014A3 Leptin-mediated gene-induction |
| 04/27/2000 | WO2000006742A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 04/27/2000 | WO2000006137A3 Glucocorticoid-selective anti-inflammatory agents |
| 04/27/2000 | WO2000006132A3 Pharmaceutical formulations comprising beclomethasone dipropionate for the treatment of inflammatory bowel disease |
| 04/27/2000 | WO2000004895A3 Nutritional and therapeutic uses of 3-hydroxyalkanoate oligomers |
| 04/27/2000 | WO2000004894A3 Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate |
| 04/27/2000 | WO2000004888A3 Use of cyclodextrins for the treatment of cerebral ischaemia and central nervous system injury |
| 04/27/2000 | WO2000004141A3 Use of nucleic acid molecules as antiviral agents |
| 04/27/2000 | WO2000003702A8 New pharmaceutical preparation and method |
| 04/27/2000 | WO2000003683A3 Liposomal encapsulated nucleic acid-complexes |
| 04/27/2000 | WO2000000618A3 Polyketides and their synthesis |
| 04/27/2000 | WO1999065460A3 Pressurized metered dose inhalers and pharmaceutical aerosol formulations comprising a beta-agonist |
| 04/27/2000 | WO1999063933A9 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 04/27/2000 | WO1999062909A9 Naphtho- and dihydrobenzo-thiophene derivatives as cytotoxic antitumor agents |
| 04/27/2000 | WO1999062459A9 Agents and methods for protection, treatment and repair of connective tissue |
| 04/27/2000 | WO1999061085A9 Method and compositions for treatment of cancers |
| 04/27/2000 | WO1999061010A3 Treatment of infertility with cam-increasing compounds alone or in combination with at least one meiosis-stimulating compound |
| 04/27/2000 | WO1999059561A3 Resveratrol inhibition of myeloperoxidase |
| 04/27/2000 | WO1999051220A9 Methods and compositions for reducing uv-induced inhibition of collagen synthesis in human skin |
| 04/27/2000 | WO1998048838A8 Compounds |
| 04/27/2000 | DE19856210A1 Use of thiol compound selected from oxidoreductase and/or hydrolase for treatment of chronic and acute tinnitus |
| 04/27/2000 | DE19849044A1 New polycythemia rubra vera-related polypeptide useful for diagnosis and for developing therapeutic antibodies |
| 04/27/2000 | DE19848856A1 Topically applied film-forming composition containing antiandrogenic N-phenyl-azolidine compound, used for treating hirsutism, seborrhea, acne or especially androgenetic alopecia |
| 04/27/2000 | DE19848521A1 Preparation of (+)-exo-6-phenyl-3-azabicyclo(3.2.0)heptane derivatives comprises photocyclization of bisallyl ammonium salts, isomer resolution using (-)-ditoluoyltartaric acid and crystallization |
| 04/27/2000 | DE19842863A1 Regulatorisches Protein aus humanen Keratinozyten Regulatory protein from human keratinocytes |
| 04/27/2000 | DE19827178A1 Stable aerosol formulations containing two or more bioactives used for pharmaceuticals |
| 04/27/2000 | CA2594186A1 Pharmaceutical composition containing decursin |
| 04/27/2000 | CA2348156A1 Human proteins involved in endoplasmic reticulum protein degradation |
| 04/27/2000 | CA2347921A1 Preparation of irrigating solution for ocular surgery |
| 04/27/2000 | CA2347910A1 Substituted benzopyran analogs for the treatment of inflammation |
| 04/27/2000 | CA2347792A1 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
| 04/27/2000 | CA2347625A1 Genes and proteins predictive and therapeutic for renal disease and associated disorders |
| 04/27/2000 | CA2347409A1 Human proteins stam2a and stam2b and cdnas encoding these molecules |
| 04/27/2000 | CA2347204A1 Compositions and methods for promoting tissue repair using heat shock proteins |
| 04/27/2000 | CA2347118A1 Propofol composition comprising pentetate |
| 04/27/2000 | CA2347108A1 Aerosol ointment compositions and method of manufacture |
| 04/27/2000 | CA2347080A1 Tnfr related gene 12 |
| 04/27/2000 | CA2347003A1 Modulation of gene expression by combination therapy |
| 04/27/2000 | CA2347001A1 Vitreous form of known bradykinin antagonist |
| 04/27/2000 | CA2346879A1 Liposome-entrapped topoisomerase inhibitors |
| 04/27/2000 | CA2346870A1 Derivatives of erythromycin, clarithromycin, roxithromycin or azithromycin with antibiotic and mucolytic activity |
| 04/27/2000 | CA2346866A1 Combination therapy with vip antagonist |
| 04/27/2000 | CA2346656A1 Methods of hydrating mucosal surfaces |
| 04/27/2000 | CA2346436A1 N-(imidazolylalkyl)substituted cyclic amines as histamine-h3 agonists or antagonists |
| 04/27/2000 | CA2346325A1 Bioflavonoids as plasma high density lipoprotein level increasing agent |
| 04/27/2000 | CA2346289A1 Pyrazolo-triazine derivatives as ligands for gaba receptors |
| 04/27/2000 | CA2345938A1 Polymorphism in a tgf-beta gene correlated to osteoporosis |
| 04/27/2000 | CA2345767A1 Therapy for improving cognition |
| 04/27/2000 | CA2345406A1 Analgesic |
| 04/27/2000 | CA2344677A1 Improving memory by the administration of .delta.5-androstene-3.beta.-ol-7,17-dione and 3.beta. esters thereof |
| 04/27/2000 | CA2344605A1 G-protein coupled receptors |
| 04/27/2000 | CA2341855A1 Method for treating schizophrenia, and means for use in this method |
| 04/27/2000 | CA2251860A1 Methods for modulating the length of telomeres by modulating the level or activity of the protease involved in the conversion of hnrnpa1 into up1 |
| 04/26/2000 | EP0995798A1 Transcription factor of MHC class II genes, substances capable of inhibiting this new transcription factor and medical uses of these substances |
| 04/26/2000 | EP0995755A1 Prodrugs of Thrombin inhibitors |
| 04/26/2000 | EP0995751A2 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction |
| 04/26/2000 | EP0995750A1 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction |
| 04/26/2000 | EP0995749A1 Process for purification and crystallisation of riboflavin |
| 04/26/2000 | EP0995748A1 Growth hormone secretagogues |
| 04/26/2000 | EP0995746A1 Prophylactic or therapeutic agent for diseases attributable to infection with helicobacters |
| 04/26/2000 | EP0995743A1 Derivatives of dihydro- and tetrahydrochinoline as a medicinal antioxydans |
| 04/26/2000 | EP0995742A1 Sulfonamide compounds and medicinal use thereof |
| 04/26/2000 | EP0995448A1 Diagnostic agents and remedies for malignant tumors |
| 04/26/2000 | EP0995447A1 Formulation comprising antibacterial substance and antiulcer substance |
| 04/26/2000 | EP0995446A2 Antithrombin III-beta containing medical preparation |
| 04/26/2000 | EP0995445A2 Ligand-mediated immunofunctional hormone binding protein assay method |
| 04/26/2000 | EP0995441A2 Combination of compounds for treating erectile dysfunctions |